3-(Benzylamino)-N-hydroxy-4-methylbenzamide, 98%, 5mg

1-(4-Fluorobenzyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 250mg

2,6,-Dimethyl-4-(1-methylethoxy)-benzenemethanol, 97%, 1g

1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 97.0%, 25g

2'-Hydroxy-4'-methoxyacetophenone>98.0%(GC)25g

(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)formamide (Afatinib Impurity), 97%, 50mg

2-Iodo-5-nitrobenzotrifluoride, 95.0%, 25g

4-Bromo-2-methylpyrimidine, 95.0%, 1g

4-Nitrophenyl beta-D-Galactopyranoside [Substrate for beta-Galactosidase]>98.0%(HPLC)5g

N-Methyl-D-valine, 97%, 5g

Benzo[d][1,3]dioxol-4-ylmethanamine, 95.0%, 100mg

THIENO[3,2-D]PYRIMIDINE, 95.0%, 250mg

Nitric acid, ROTI®Volum 0.1 mol/l - 0.1 N, ampoule, 1 piece, glass packaging